Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Changhai Hospital is the lead sponsor of 81 current clinical trials in our China register. 51 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Pronase, Abiraterone and Cyclophosphamide. The most-studied condition is Pancreatic Cancer.

ClinicalTrials.gov trials by status

Recruiting5163%
Not yet open1822%
Active, closed1012%
By invitation22%

Trials by phase

Not applicable3543%
Observational2328%
Phase 167%
Phase 267%
Phase EARLY_PHASE156%
Phase 422%
Phase 2/322%
Phase 311%
Phase 1/211%

Clinical trials sponsored by Changhai Hospital

81 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) NCT04743479 · Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer	Observational	Recruiting	2020-12	China
Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer NCT06325995 · ClinicalTrials.gov ↗ · Localized Prostate Cancer	Not applicable	Recruiting	2024-02	China
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort NCT06638866 · ClinicalTrials.gov ↗ · Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraepithelial Neoplasias	Observational	Recruiting	2024-08	China
RIRS With Flex Suction Sheath vs. PCNL for 2-3 cm Renal Stones NCT07058402 · ClinicalTrials.gov ↗ · Nephrolithiasis	Not applicable	Recruiting	2025-04	China
Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis NCT07088757 · ClinicalTrials.gov ↗ · Post-ERCP Pancreatitis Drug: Indomethacin	Phase 4	Recruiting	2025-09	China
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors NCT07492693 · ClinicalTrials.gov ↗ · Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors	Phase 2	Recruiting	2024-10	China
Effect of Premedication With Pronase on Mucosal Cleanliness During EGD NCT06713421 · ClinicalTrials.gov ↗ · Esophageal Cancer, Gastric Cancer Drug: Pronase	Not applicable	Recruiting	2024-12	China
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) NCT06427460 · ClinicalTrials.gov ↗ · Pancreatic Cancer	Phase 2	Recruiting	2024-05	China
Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) NCT06427447 · ClinicalTrials.gov ↗ · Pancreatic Cancer	Phase 3	Recruiting	2024-08	China
An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease NCT07241468 · ClinicalTrials.gov ↗ · Relapsed/Refractory Immune Nephropathy, Relapsed/Refractory Immune-mediated Kidney Disease	Phase EARLY_PHASE1	Recruiting	2025-11	China
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients NCT06885710 · ClinicalTrials.gov ↗ · Chronic Hepatitis b	Phase 1	Recruiting	2024-12	China
Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis NCT07153809 · ClinicalTrials.gov ↗ · Acute Pancreatitis, Severe Acute Pancreatitis	Not applicable	Recruiting	2024-10	China
High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib NCT06394674 · ClinicalTrials.gov ↗ · Non-Small Cell Lung Cancer Drug: Furmonertinib	Phase 2	Recruiting	2024-05	China
Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions NCT07462247 · ClinicalTrials.gov ↗ · Upper Gastrointestinal Cancer, Upper Gastrointestinal Precancerous Lesions, Upper Gastrointestinal Precancerous Conditions	Observational	Recruiting	2026-03	China
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases NCT05240950 · ClinicalTrials.gov ↗ · Colorectal Cancer, Metastatic Liver Cancer	Phase 1	Recruiting	2022-08	China
Direct Visualization ERAT Versus Laparoscopic Appendectomy in Adults With Acute Uncomplicated Appendicitis NCT07230379 · ClinicalTrials.gov ↗ · Acute Uncomplicated Appendicitis	Not applicable	Recruiting	2025-12	China
Translation and Validation of Chinese COMPAT-SF NCT06917716 · ClinicalTrials.gov ↗ · Chronic Pancreatitis	Observational	Recruiting	2025-03	China
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients NCT07335705 · ClinicalTrials.gov ↗ · IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation	Observational	Recruiting	2025-12	China
Adjuvant Hypofractionated Radiotherapy for Prostate Cancer NCT06335693 · ClinicalTrials.gov ↗ · Prostate Cancer	Not applicable	Recruiting	2024-03	China
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy NCT07202559 · ClinicalTrials.gov ↗ · Pancreatitis, Chronic, Pancreatitis, Acute, Pancreatic Duct Stones	Not applicable	Recruiting	2025-10	China
Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer NCT06889623 · ClinicalTrials.gov ↗ · NMIBC	Not applicable	Recruiting	2024-06	China
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer NCT06816823 · ClinicalTrials.gov ↗ · Pancreatic Cancer	Phase 1	Recruiting	2025-04	China
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration NCT07307456 · ClinicalTrials.gov ↗ · Bladder Cancer	Phase 2	Recruiting	2025-12	China
Metformin in Post Chronic Pancreatitis Diabetes Mellitus NCT06937294 · ClinicalTrials.gov ↗ · Chronic Pancreatitis Drug: Metformin	Phase 4	Recruiting	2025-04	China
Natural Course and Therapeutic Effect of Chronic Pancreatitis NCT06925204 · ClinicalTrials.gov ↗ · Chronic Pancreatitis	Observational	Recruiting	2025-04	China
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer NCT04146298 · ClinicalTrials.gov ↗ · Pancreatic Cancer, Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma Drugs: Cyclophosphamide, Fludarabine	Phase 1/2	Recruiting	2021-10	China
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer NCT07117045 · ClinicalTrials.gov ↗ · Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, High-grade Pancreatic Intraepithelial Neoplasia	Observational	Recruiting	2025-08	China
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT) NCT06292585 · ClinicalTrials.gov ↗ · EpiDural Hematoma, Traumatic Brain Injury	Not applicable	Recruiting	2024-09	China
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer NCT06346093 · ClinicalTrials.gov ↗ · Advanced Gastric Cancer	Not applicable	Recruiting	2024-04	China
FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis NCT07464392 · ClinicalTrials.gov ↗ · Acute Pancreatitis Drug: Fecal Microbiota Transplantation	Not applicable	Recruiting	2026-04	China
Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma NCT05869474 · ClinicalTrials.gov ↗ · Metastatic Pancreatic Cancer	Not applicable	Recruiting	2023-08	China
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus NCT06010472 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus (SLE)	Phase EARLY_PHASE1	Recruiting	2023-08	China
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases NCT07246096 · ClinicalTrials.gov ↗ · Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Sclerosis	Phase EARLY_PHASE1	Recruiting	2026-02	China
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy NCT06878378 · ClinicalTrials.gov ↗ · Colonoscopy, Colonoscopy: Bowel Preparation	Observational	Recruiting	2025-02	China
CAR-NK Cells (CL-NK-003) in Pancreatic Cancer NCT07425483 · ClinicalTrials.gov ↗ · Pancreatic Cancer	Phase 1	Recruiting	2026-02	China
An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases NCT06464679 · ClinicalTrials.gov ↗ · Autoimmune Diseases	Phase 1	Recruiting	2024-06	China
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis NCT07047339 · ClinicalTrials.gov ↗ · Colitis, IBD (Inflammatory Bowel Disease), Probiotic Intervention	Phase 2/3	Recruiting	2025-07	China
Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy NCT07204132 · ClinicalTrials.gov ↗ · Bladder Cancer	Not applicable	Recruiting	2025-09	China
Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis NCT06355206 · ClinicalTrials.gov ↗ · Cohort Study, Recurrent Acute Pancreatitis	Observational	Recruiting	2024-04	China
THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein NCT05194423 · ClinicalTrials.gov ↗ · Tricuspid Valve Regurgitation	Not applicable	Recruiting	2022-03	China
Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis NCT06655051 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Benign Biliary Stricture	Not applicable	Recruiting	2025-04	China
Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis NCT07074379 · ClinicalTrials.gov ↗ · Painless Chronic Pancreatitis	Not applicable	Recruiting	2025-07	China
Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease NCT07353853 · ClinicalTrials.gov ↗ · IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation	Not applicable	Recruiting	2026-01	China
AI-Powered Precision Decision-Making for Pancreatic Diseases NCT07439757 · ClinicalTrials.gov ↗ · Pancreatic Cancer, Diagnose Disease, IPMN, Pancreatic	Observational	Recruiting	2026-03	China
Evaluation of a CAM System for Colorectal Polyp Size Measurement NCT06715384 · ClinicalTrials.gov ↗ · Colorectal Polyp, Colorectal Adenoma	Not applicable	Recruiting	2024-12	China
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis NCT07036991 · ClinicalTrials.gov ↗ · Carotid Artery Stenosis	Observational	Recruiting	2025-09	China
Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study NCT05864638 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy	Observational	Recruiting	2023-05	China
Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy NCT06728826 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Cardiac Events, Pericardial Effusion	Not applicable	Recruiting	2025-12	China
Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease NCT07165470 · ClinicalTrials.gov ↗ · Colonoscopy: Bowel Preparation, IBD - Inflammatory Bowel Disease	Not applicable	Recruiting	2025-09	China
Radical Hypofractionated Radiotherapy for Localized Prostate Cancer NCT06325774 · ClinicalTrials.gov ↗ · Localized Prostate Cancer	Not applicable	Recruiting	2024-09	China
An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy NCT06469190 · ClinicalTrials.gov ↗ · Nephropathy	Phase EARLY_PHASE1	Recruiting	2024-06	China
Triple Branched Stent Graft System for Aortic Arch Lesions NCT07067840 · ClinicalTrials.gov ↗ · Aortic Arch Aneurysm, Aortic Arch Pseudoaneurysm, Aortic Arch Ulcer	Not applicable	Not yet open	2025-09	China
An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related Disease NCT07298590 · ClinicalTrials.gov ↗ · IgG4 Related Disease	Phase EARLY_PHASE1	Not yet open	2025-12	China
Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions NCT07507071 · ClinicalTrials.gov ↗ · Early Gastric Cancer	Observational	Not yet open	2026-03	China
Impact of Acetic Acid-Indigo Carmine Chromocolonoscopy on Proximal Sessile Serrated Lesions NCT07601217 · ClinicalTrials.gov ↗ · Sessile Serrated Lesion	Not applicable	Not yet open	2026-06	China
Pulsed Field Ablation of SVC and PV in Paroxysmal Atrial Fibrillation (PASPA Study) NCT07191626 · ClinicalTrials.gov ↗ · Paroxysmal Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF)	Not applicable	Not yet open	2025-11	China
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer NCT07134218 · ClinicalTrials.gov ↗ · Rectal Cancer	Phase 2/3	Not yet open	2025-10	China
Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis NCT06874673 · ClinicalTrials.gov ↗ · Pronase, Mucosal Clarity Drug: Pronase	Not applicable	Not yet open	2025-03	China
Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD NCT07088744 · ClinicalTrials.gov ↗ · Gastric Cancer (Diagnosis), Gastric High-grade Intraepithelial Neoplasia, Gastric Low-grade Intraepithelial Neoplasia	Observational	Not yet open	2025-07	China
The 22G Franseen Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy NCT07023549 · ClinicalTrials.gov ↗ · Pancreatic Diseases	Not applicable	Not yet open	2025-07	China
Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions NCT06994611 · ClinicalTrials.gov ↗ · Pancreatic Diseases	Not applicable	Not yet open	2025-06	China
The 22G Trident Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy NCT07023562 · ClinicalTrials.gov ↗ · Pancreatic Diseases	Not applicable	Not yet open	2025-06	China
Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma NCT06927128 · ClinicalTrials.gov ↗ · UTUC, NAC	Phase 2	Not yet open	2025-05	China
Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer NCT05707468 · ClinicalTrials.gov ↗ · Oligometastatic Prostate Carcinoma	Not applicable	Not yet open	2024-05	China
MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding NCT06698874 · ClinicalTrials.gov ↗ · Gastrointestinal Bleeding, Antiplatelet Therapy	Not applicable	Not yet open	2024-12	China
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria NCT06469229 · ClinicalTrials.gov ↗ · Hematuria, Urothelial Carcinoma, Bladder Cancer	Observational	Not yet open	2024-07	China
Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer NCT06198387 · ClinicalTrials.gov ↗ · Oligo-metastatic Prostate Carcinoma Drug: Abiraterone	Not applicable	Not yet open	2024-01	China
Colorectal Adenoma Canceration in FAP NCT04531930 · ClinicalTrials.gov ↗ · Familial Adenomatous Polyposis	Observational	Not yet open	2020-10	China
Detachable String Magnetically Controlled Capsule Endoscopy for Patients with AUGIB NCT06725056 · ClinicalTrials.gov ↗ · Acute Upper Gastrointestinal Bleeding, Capsule Endoscopes	Not applicable	Not yet open	2024-12	China
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer NCT07583160 · ClinicalTrials.gov ↗ · Metastatic Castration-Resistant Prostate Cancer Patients, Castration-Resistant Prostate Cancer (CRPC), Prostate Neoplasms	Phase 1	By invitation	2026-06	China
Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia NCT06984055 · ClinicalTrials.gov ↗ · Esophageal Cancer, Squamous Cell	Observational	By invitation	2025-03	China
Carotid Plaque Length to Predict Cardiovascular Events NCT05409209 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Observational	Active, closed	2017-01	China
A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma NCT07155044 · ClinicalTrials.gov ↗ · UTUC, UC (Urothelial Cancer)	Observational	Active, closed	2024-05	China
Association Between Carotid Plaque Length and Cardiovascular Outcomes NCT05843487 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Carotid Plaque	Observational	Active, closed	2017-01	China
Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial NCT07492225 · ClinicalTrials.gov ↗ · Neoadjuvant Therapy, Urothelial Carcinoma Ureter, Upper Urinary Tract Urothelial Carcinoma	Phase 2	Active, closed	2025-08	China
Association Between Carotid Plaque Length and Cardiovascular Events NCT05159804 · ClinicalTrials.gov ↗ · Coronary Arteriosclerosis	Observational	Active, closed	2017-01	China
Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study NCT05639010 · ClinicalTrials.gov ↗ · End Stage Renal Disease	Not applicable	Active, closed	2023-01	China
Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy NCT06581653 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Pancreatic Exocrine Insufficiency	Not applicable	Active, closed	2024-08	China
The Natural History of Chronic Pancreatitis NCT03324698 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Complication, Risk Factors	Observational	Active, closed	2000-01	China
An Observational Study on Post-chronic Pancreatitis Diabetes Mellitus NCT05764629 · ClinicalTrials.gov ↗ · Chronic Pancreatitis, Diabetes Mellitus	Observational	Active, closed	2021-09	China
Multicenter Clinical Randomized Controlled Trial of Unilateral Biportal Endoscopic Spinal Surgery for Degenerative Grade 1 Spondylolisthesis Complicated With Lumbar Spinal Stenosis NCT07303348 · ClinicalTrials.gov ↗ · Lumbar Spinal Stenosis (LSS), Degenerative Spondylolisthesis G1	Not applicable	Active, closed	2025-07	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Changhai Hospital trials

8 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Pronase2 Abiraterone1 Cyclophosphamide1 Fecal Microbiota Transplantation1 Fludarabine1 Furmonertinib1 Indomethacin1 Metformin1

Conditions in Changhai Hospital trials

116 conditions

Pancreatic Cancer9Chronic Pancreatitis7Colonoscopy: Bowel Preparation4IBD (Inflammatory Bowel Disease)3Colonoscopy3Pancreatic Diseases3Bladder Cancer3Localized Prostate Cancer2Pancreatic Ductal Adenocarcinoma2Intraductal Papillary Mucinous Neoplasm2Coronary Artery Disease2Acute Pancreatitis2UTUC2Autoimmune Diseases2 Diabetes1Familial Pancreatic Cancer1Pancreatic Cystic Neoplasm1Aortic Arch Aneurysm1Aortic Arch Pseudoaneurysm1Aortic Arch Ulcer1Pancreatic Intraepithelial Neoplasias1Nephrolithiasis1Metastatic Castration-Resistant Prostate Cancer Patients1Castration-Resistant Prostate Cancer (CRPC)1

By trial register

Register	Trials	Recruiting
Clinical trials in China	81	51

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Pancreatic Cancer

Sponsor	Trials
Fudan University	14
Ruijin Hospital	7
Tianjin Medical University Cancer Institute and Hospital	7
Peking Union Medical College Hospital	7
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	6
Revolution Medicines	5
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	4
CARsgen Therapeutics	3
Shandong Cancer Hospital and Institute	3
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	3

Sponsors with the most current trials registered for this condition.

Questions about Changhai Hospital trials

How many clinical trials does Changhai Hospital sponsor?

Changhai Hospital is the lead sponsor of 81 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Changhai Hospital trials recruiting?

Yes. 51 of its 81 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Changhai Hospital testing?

Its current trials name 8 drugs and biologicals as interventions. The most frequent are Pronase (2), Abiraterone (1), Cyclophosphamide (1), Fecal Microbiota Transplantation (1) and Fludarabine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Changhai Hospital clinical trials